Chronic Myelomonocytic Leukemia clinical trials in Illinois
6 active Chronic Myelomonocytic Leukemia trials with a site in Illinois. Describe your situation to see which ones look like a fit.
- A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
- Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.